This company seems to have been delisted
Reason: Merged with Ayala Pharmaceuticals
Source: https://ir.ayalapharma.com/news-releases/news-release-details/advaxis-and-ayala-pharmaceuticals-complete-merger
Reason: Merged with Ayala Pharmaceuticals
Source: https://ir.ayalapharma.com/news-releases/news-release-details/advaxis-and-ayala-pharmaceuticals-complete-merger
Advaxis
ADXS
HK$0.23
Share price
0.00%
Change (1 day)
-94.95%
Change (1 year)
Categories
Advaxis (ADXS) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : HK$0.31 Billion
According to Advaxis's latest financial reports the company's total liabilities are HK$0.31 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Advaxis - Total liabilities on balance sheet (from 2019 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | HK$0.32 B | 362.1% |
| 2022-12-31 | HK$69.28 M | 27.51% |
| 2021-12-31 | HK$54.34 M | -5.66% |
| 2020-12-31 | HK$57.59 M | -87.46% |
| 2019-12-31 | HK$0.45 B | 19.74% |
| 2018-12-31 | HK$0.38 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 | HK$0.34 B | 9.02% | 🇺🇸 USA |
 | HK$0.20 B | -35.60% | 🇺🇸 USA |
 | HK$1.36 B | 326.98% | 🇺🇸 USA |